About Lee Schoentrup

This author has not yet filled in any details.
So far Lee Schoentrup has created 87 blog entries.

Seattle Lawyer Cindy Runger Joins IDRI Board of Directors

October 19th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle, WA | Oct. 19, 2017: Cindy Runger, a senior finance and legal executive who most recently served in a leadership role with U.S. Trust, has joined the Board of Directors of IDRI (Infectious Disease Research [...]

Site of First Human Study of Vaccine for Leprosy

October 13th, 2017|News|

First Leprosy Vaccine Makes Initial Step Toward Human Use

October 13th, 2017|News|

Promising New Leprosy Vaccine Moves into Human Trials

October 12th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: SEATTLE, WA, & GREENVILLE, SC | Oct. 12, 2017: Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a [...]

IDRI Collaborates on Novel Vaccine for Ebola & Other Hemorrhagic Fever Viruses

October 5th, 2017|Press Releases|

FOR IMMEDIATE RELEASE: Seattle | Oct. 5, 2017: IDRI (Infectious Disease Research Institute) is part of a new consortium formed to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg, and Lassa fever viruses. If successful, [...]

5th Annual Around the World with IDRI Celebration

September 13th, 2017|Events|

Thursday, Oct. 19, 2017 Event Details: 5th annual Around the World with IDRI Celebration Thursday, Oct. 19, 2017 5:30-8:30 p.m. - open house; 7 p.m. - global health interactive panel discussion IDRI 1616 Eastlake Avenue East, Suite 400 Seattle, WA [...]

Hurricane Harvey Highlights Need for Vaccines

August 31st, 2017|Blog|

When a natural disaster – like Hurricane Harvey – hits, one of the immediate effects is often flooding. As waters rise, people and animals are in danger and become displaced. With the onslaught of rain during Harvey, contact with water [...]

Quratis Teams with IDRI on TB Vaccine

August 30th, 2017|Press Releases|

SEATTLE & SEOUL | Aug. 30, 2017 FOR IMMEDIATE RELEASE: Quratis Inc. announced Wednesday that the company had applied for the phase 2 of clinical trials in Korea for an adult tuberculosis vaccine developed by scientists at the Infectious Disease Research Institute [...]

IDRI Continues Development of Inhalable TB Drug

August 28th, 2017|News|

IDRI to Continue Development of Inhalable TB Drug Candidate

August 24th, 2017|Press Releases|

  IDRI's Steve Reed, left, signs TB agreement with Hisun officials as part of a ceremony to commemorate the 30th anniversary of the friendship relationship between the state of Indiana and Zheijiang Province. SEATTLE | Aug. 24, 2017 FOR [...]

Load More